Table 3.
Univariable and multivariable analysis of parameters predicting 30-day mortality.
| Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
| Serum lactate (baseline) | 1.09 | 1.04–1.13 | <0.001 | 1.10 | 1.05–1.15 | <0.001 |
| Serum creatine (baseline) | 1.001 | 0.99–1.002 | 0.3 | |||
| C-reactive protein (baseline) | 0.998 | 0.966–1.031 | 0.92 | |||
| ASAT (baseline) | 1.007 | 0.996–1.018 | 0.23 | |||
| Troponin (baseline) | 1.00 | 0.999–1.002 | 0.59 | |||
| Hemoglobin (baseline) | 0.87 | 0.79–0.96 | 0.004 | 0.86 | 0.78–0.95 | 0.002 |
| Lactate Clearance (after 6 h) | 0.998 | 0.992–1.003 | 0.44 | |||
| Lactate Clearance (after 12 h) | 0.996 | 0.991–1.002 | 0.19 | |||
| Lactate Clearance (after 24 h) | 0.998 | 0.992–1.004 | 0.47 | |||
| Noradrenalin use | 3.05 | 1.38–6.70 | 0.006 | 2.40 | 1.06–5.44 | 0.04 |
| Dobutamin use | 2.15 | 1.29–3.57 | 0.003 | 1.78 | 1.05–3.04 | 0.03 |
| Suprarenin use | 0.68 | 0.42–1.10 | 0.11 | |||
| Bystander BLS | 0.86 | 0.37–2.02 | 0.73 | |||
| OHCA | 1.35 | 0.78–2.35 | 0.28 | |||
| AMI | 0.96 | 0.56–1.67 | 0.9 | |||
| Age | 1.01 | 0.995–1.031 | 0.16 | |||
| Male sex | 1.07 | 0.62–1.86 | 0.81 | |||
| CPR duration | 1.003 | 0.997–1.010 | 0.26 | |||
| Ventricular fibrillation | 0.78 | 0.45–1.35 | 0.36 | |||
| pH (baseline) | 0.29 | 0.15–0.55 | <0.001 | 0.42 | 0.16–1.10 | 0.08 |
OHCA: out-of-hospital cardiac arrest; CPR: cardiopulmonary resuscitation; AMI: acute myocardial infarction; BLS: basic life support. HR, hazard ratio; CI, confidence interval.